213 related articles for article (PubMed ID: 26687209)
1. Synthesis, cytotoxicity and anti-cancer activity of new alkynyl-gold(I) complexes.
De Nisi A; Bergamini C; Leonzio M; Sartor G; Fato R; Naldi M; Monari M; Calonghi N; Bandini M
Dalton Trans; 2016 Jan; 45(4):1546-53. PubMed ID: 26687209
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization and cytotoxicity of the gold(III) complexes of 4,5-dihydropyrazole-1-carbothioamide derivatives.
Wang S; Shao W; Li H; Liu C; Wang K; Zhang J
Eur J Med Chem; 2011 May; 46(5):1914-8. PubMed ID: 21392862
[TBL] [Abstract][Full Text] [Related]
3. The fluxional amine gold(III) complex as an excellent catalyst and precursor of biologically active acyclic carbenes.
Montanel-Pérez S; Herrera RP; Laguna A; Villacampa MD; Gimeno MC
Dalton Trans; 2015 May; 44(19):9052-62. PubMed ID: 25893402
[TBL] [Abstract][Full Text] [Related]
4. In vitro anticancer activity of gold(III) complexes with some esters of (S,S)-ethylenediamine-N,N'-di-2-propanoic acid.
Pantelić N; Stanojković TP; Zmejkovski BB; Sabo TJ; Kaluđerović GN
Eur J Med Chem; 2015 Jan; 90():766-74. PubMed ID: 25528331
[TBL] [Abstract][Full Text] [Related]
5. Gold amides as anticancer drugs: synthesis and activity studies.
Newcombe S; Bobin M; Shrikhande A; Gallop C; Pace Y; Yong H; Gates R; Chaudhuri S; Roe M; Hoffmann E; Viseux EM
Org Biomol Chem; 2013 May; 11(19):3255-60. PubMed ID: 23584015
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterisation and biological properties of gold(III) compounds with modified bipyridine and bipyridylamine ligands.
Casini A; Diawara MC; Scopelliti R; Zakeeruddin SM; Grätzel M; Dyson PJ
Dalton Trans; 2010 Mar; 39(9):2239-45. PubMed ID: 20162197
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of heterobimetallic gold(i) ferrocenyl-substituted 1,2,3-triazol-5-ylidene complexes as potential anticancer agents.
Aucamp D; Kumar SV; Liles DC; Fernandes MA; Harmse L; Bezuidenhout DI
Dalton Trans; 2018 Nov; 47(45):16072-16081. PubMed ID: 30276400
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structural characterisation and anti-proliferative activity of NHC gold amino acid and peptide conjugates.
Lemke J; Pinto A; Niehoff P; Vasylyeva V; Metzler-Nolte N
Dalton Trans; 2009 Sep; (35):7063-70. PubMed ID: 20449149
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of Pyrazine-Based Cyclometalated (C^N
Bertrand B; Fernandez-Cestau J; Angulo J; Cominetti MMD; Waller ZAE; Searcey M; O'Connell MA; Bochmann M
Inorg Chem; 2017 May; 56(10):5728-5740. PubMed ID: 28441013
[TBL] [Abstract][Full Text] [Related]
10. Gold complexes with benzimidazole derivatives: synthesis, characterization and biological studies.
Mota VZ; de Carvalho GS; da Silva AD; Costa LA; de Almeida Machado P; Coimbra ES; Ferreira CV; Shishido SM; Cuin A
Biometals; 2014 Feb; 27(1):183-94. PubMed ID: 24442571
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of polymeric gold glyco-conjugates as anti-cancer agents.
Ahmed M; Mamba S; Yang XH; Darkwa J; Kumar P; Narain R
Bioconjug Chem; 2013 Jun; 24(6):979-86. PubMed ID: 23631753
[TBL] [Abstract][Full Text] [Related]
12. A potential antitumor agent, (6-amino-1-methyl-5-nitrosouracilato-N3)-triphenylphosphine-gold(I): structural studies and in vivo biological effects against experimental glioma.
Illán-Cabeza NA; García-García AR; Martínez-Martos JM; Ramírez-Expósito MJ; Peña-Ruiz T; Moreno-Carretero MN
Eur J Med Chem; 2013 Jun; 64():260-72. PubMed ID: 23644209
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships in cytotoxic Au(I)/Au(III) complexes derived from 2-(2'-pyridyl)benzimidazole.
Maiore L; Aragoni MC; Deiana C; Cinellu MA; Isaia F; Lippolis V; Pintus A; Serratrice M; Arca M
Inorg Chem; 2014 Apr; 53(8):4068-80. PubMed ID: 24679072
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of lipoxygenase (LOX) and anticancer activity caused by gold(I) mixed ligands complexes of triphenylphosphine and thioamides.
Georgiou E; Metsios A; Kourkoumelis N; Karkabounas S; Charalabopoulos K; Badeka A; Hadjikakou SK
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):592-7. PubMed ID: 21087193
[TBL] [Abstract][Full Text] [Related]
15. Exploring the C^N^C theme: Synthesis and biological properties of tridentate cyclometalated gold(III) complexes.
Jürgens S; Scalcon V; Estrada-Ortiz N; Folda A; Tonolo F; Jandl C; Browne DL; Rigobello MP; Kühn FE; Casini A
Bioorg Med Chem; 2017 Oct; 25(20):5452-5460. PubMed ID: 28823538
[TBL] [Abstract][Full Text] [Related]
16. NHC gold halide complexes derived from 4,5-diarylimidazoles: synthesis, structural analysis, and pharmacological investigations as potential antitumor agents.
Liu W; Bensdorf K; Proetto M; Abram U; Hagenbach A; Gust R
J Med Chem; 2011 Dec; 54(24):8605-15. PubMed ID: 22091836
[TBL] [Abstract][Full Text] [Related]
17. Luminescent alkynyl-gold(I) coumarin derivatives and their biological activity.
Arcau J; Andermark V; Aguiló E; Gandioso A; Moro A; Cetina M; Lima JC; Rissanen K; Ott I; Rodríguez L
Dalton Trans; 2014 Mar; 43(11):4426-36. PubMed ID: 24302256
[TBL] [Abstract][Full Text] [Related]
18. Gold(I) complexes with alkylated PTA (1,3,5-triaza-7-phosphaadamantane) phosphanes as anticancer metallodrugs.
García-Moreno E; Gascón S; Atrián-Blasco E; Rodriguez-Yoldi MJ; Cerrada E; Laguna M
Eur J Med Chem; 2014 May; 79():164-72. PubMed ID: 24732792
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of gold(I) phosphine complexes containing the 2-BrC
Reddy TS; Privér SH; Mirzadeh N; Bhargava SK
Eur J Med Chem; 2018 Feb; 145():291-301. PubMed ID: 29331752
[TBL] [Abstract][Full Text] [Related]
20. New Derivatives of Bacteriopurpurin with Thiolated Au (I) Complexes: Dual Darkand Light Activated Antitumor Potency.
Grin MA; Tikhonov SI; Petrova AS; Pogorilyy VA; Noev АN; Tatarskiy VV; Shpakovsky DB; Milaeva ER; Kalinina EV; Chernov NN; Shtil АА; Mironov AF; Kaprin AD; Filonenko EV
Anticancer Agents Med Chem; 2020; 20(1):49-58. PubMed ID: 31368879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
